Citadel Advisors’s Indaptus Therapeutics INDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-550
| Closed | -$19.1K | – | 6355 |
|
|
2024
Q3 | $19.1K | Sell |
550
-243
| -31% | -$8.43K | ﹤0.01% | 5345 |
|
|
2024
Q2 | $47.1K | Buy |
+793
| New | +$47.1K | ﹤0.01% | 5196 |
|
|
2024
Q1 | – | Sell |
-590
| Closed | -$29.2K | – | 6463 |
|
|
2023
Q4 | $29.2K | Buy |
+590
| New | +$29.2K | ﹤0.01% | 5277 |
|
|
2022
Q4 | – | Sell |
-389
| Closed | -$24K | – | 6373 |
|
|
2022
Q3 | $24K | Buy |
+389
| New | +$24K | ﹤0.01% | 5499 |
|
|
2021
Q4 | – | Sell |
-508
| Closed | -$111K | – | 6789 |
|
|
2021
Q3 | $111K | Buy |
508
+398
| +362% | +$87K | ﹤0.01% | 5804 |
|
|
2021
Q2 | $43K | Sell |
110
-90
| -45% | -$35.2K | ﹤0.01% | 6231 |
|
|
2021
Q1 | $98K | Sell |
200
-215
| -52% | -$105K | ﹤0.01% | 5866 |
|
|
2020
Q4 | $160K | Buy |
415
+392
| +1,704% | +$151K | ﹤0.01% | 4571 |
|
|
2020
Q3 | $13K | Sell |
23
-109
| -83% | -$61.6K | ﹤0.01% | 4569 |
|
|
2020
Q2 | $84K | Buy |
132
+78
| +144% | +$49.6K | ﹤0.01% | 4275 |
|
|
2020
Q1 | $23K | Buy |
54
+36
| +200% | +$15.3K | ﹤0.01% | 4644 |
|
|
2019
Q4 | $20K | Sell |
18
-20
| -53% | -$22.2K | ﹤0.01% | 4506 |
|
|
2019
Q3 | $63K | Buy |
+38
| New | +$63K | ﹤0.01% | 4330 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4871 |
|